Murine lupus genetics: lessons learned.

Recent reverse genetic studies in murine lupus have taught us the following lessons: (1) Lupus is extremely polygenic; (2) A single locus may be associated with many different phenotypes; (3) What appears to be a single locus may turn out to be a cluster of loci; (4) Different loci facilitate different immunologic steps leading to lupus; (5) Epistatic interactions between loci may engender novel autoimmune phenotypes; (6) Whereas some loci may be pathogenic, others may confer disease resistance; (7) Whereas the expression of some loci is sex-dependent, the expression of others clearly is not; (8) Two or more loci may have an impact on the same phenotype; (9) Lupus susceptibility loci appear to co-cluster with other autoimmunity susceptibility loci; (10) Lupus genes are likely to be polymorphic alleles with subtle impacts, rather than outright mutations with extreme functions. In contrast, forward genetic studies have revealed that molecules that impact apoptosis, the clearance of apoptotic cells, B-cell or T-cell function, and end-organ pathology can all potentially contribute to lupus. Collectively, the loci and genes identified by these two different approaches factorize into a few distinct pathways leading to lupus. Delineating the molecular mediators of these distinct checkpoints is the challenge that lies ahead.

[1]  L. Hood,et al.  Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Vaux,et al.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Croker,et al.  Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. , 1999, The Journal of clinical investigation.

[4]  B. Olsen,et al.  Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[5]  J. Ravetch,et al.  Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. , 1998, Science.

[6]  R. Eisenberg,et al.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.

[7]  J. Lunceford,et al.  Physical mapping of the autoimmune disease susceptibility locus, Bphs: co-localization with a cluster of genes from the TNF receptor superfamily on mouse Chromosome 6 , 1999, Mammalian Genome.

[8]  T. Yamazaki,et al.  Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. , 1998, The Journal of clinical investigation.

[9]  C. Drake,et al.  Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. , 1995, Journal of immunology.

[10]  J. Flores,et al.  Increased phosphoinositide 3‐kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  E. Remmers,et al.  Genetic factors regulating experimental arthritis in mice and rats. , 1999, Current directions in autoimmunity.

[12]  C. Drake,et al.  Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. , 1996, The Journal of clinical investigation.

[13]  C. Drake,et al.  Effect of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Holmdahl Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis. , 1998, Current opinion in immunology.

[15]  T. Möröy,et al.  Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.

[16]  T. Glant,et al.  A Genome Scan Using a Novel Genetic Cross Identifies New Susceptibility Loci and Traits in a Mouse Model of Rheumatoid Arthritis1 , 2000, The Journal of Immunology.

[17]  P. Pandolfi,et al.  Impaired Fas response and autoimmunity in Pten+/- mice. , 1999, Science.

[18]  B. Croker,et al.  Functional dissection of systemic lupus erythematosus using congenic mouse strains. , 1997, Journal of immunology.

[19]  T. Yamamoto,et al.  Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. , 1995, Immunity.

[20]  Don Foster,et al.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.

[21]  P. Butler,et al.  Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity , 1999, Nature Medicine.

[22]  M. Walport,et al.  Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice. , 2000, Arthritis and rheumatism.

[23]  R. Doerge,et al.  Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. , 1999, Journal of immunology.

[24]  R. Doerge,et al.  Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. , 1999, Journal of immunology.

[25]  K. Siminovitch,et al.  Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. , 1994, Clinical immunology and immunopathology.

[26]  Nose Genome analysis of collagen disease in MRL/lpr mice: polygenic inheritance resulting in the complex pathological manifestations , 2000, International journal of cardiology.

[27]  J. Seidman,et al.  Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. , 1996, Journal of immunology.

[28]  D. Kono,et al.  Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. , 1998, The Journal of clinical investigation.

[29]  C. Mohan,et al.  Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. , 1999, Journal of immunology.

[30]  M. Inaoki,et al.  The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. , 1997, Immunity.

[31]  M. Serrano,et al.  The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development , 2000, Nature Medicine.

[32]  M. Potter,et al.  Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. , 1994, Cancer research.

[33]  J. Todd,et al.  Mapping of the IDDM Locus Idd3 to a 0.35-cM Interval Containing the Interleukin-2 Gene , 1997, Diabetes.

[34]  A. DeFranco,et al.  Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn , 2001, Current Biology.

[35]  H. Nishimura,et al.  Multigenic control of lupus‐associated antiphospholipid syndrome in a model of (NZW × BXSB) F1 mice , 1998 .

[36]  E. Wakeland,et al.  Polygenic control of susceptibility to murine systemic lupus erythematosus. , 1994, Immunity.

[37]  G. Núñez,et al.  Constitutive expression of bcl-2 in B cells causes a lethal form of lupuslike autoimmune disease after induction of neonatal tolerance to H- 2b alloantigens , 1996, The Journal of experimental medicine.

[38]  B. Rollins,et al.  Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. , 1999, The Journal of clinical investigation.

[39]  R. Balderas,et al.  Lupus susceptibility loci in New Zealand mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Seidman,et al.  QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2 , 1999, Nature Genetics.

[41]  C. Mohan,et al.  Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. , 1997, Journal of immunology.

[42]  J. Alexander,et al.  Immune complex glomerulonephritis in C4- and C3-deficient mice. , 1998, Kidney international.

[43]  K. Tung,et al.  A common immunoregulatory locus controls susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis in BALB/c mice. , 1998, Journal of immunology.

[44]  T. Honjo,et al.  Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. , 1999, Immunity.

[45]  H. Weiner,et al.  Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice. , 1999, Journal of immunology.

[46]  K. Blenman,et al.  Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Mohan,et al.  Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. , 1998, Arthritis and rheumatism.

[48]  S. Stacker,et al.  Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease , 1995, Cell.

[49]  R. Tucker,et al.  Genetic Control of Glycoprotein 70 Autoantigen Production and Its Influence on Immune Complex Levels and Nephritis in Murine Lupus1 , 2000, The Journal of Immunology.

[50]  S. Mori,et al.  Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance. , 1999, Arthritis and rheumatism.

[51]  C. Goodnow,et al.  CD19-Regulated Signaling Thresholds Control Peripheral Tolerance and Autoantibody Production in B Lymphocytes , 1997, The Journal of experimental medicine.

[52]  P. Lyons,et al.  Localising quantitative trait loci in the NOD mouse model of type 1 diabetes. , 1999, Current directions in autoimmunity.

[53]  J. Todd,et al.  New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. , 1998, Journal of immunology.

[54]  R. Holmdahl,et al.  Genetic linkage analysis of collagen‐induced arthritis in the mouse , 1998, European journal of immunology.

[55]  C. Mohan,et al.  Multiplex inheritance of component phenotypes in a murine model of lupus , 1999, Mammalian Genome.

[56]  M. Neuberger,et al.  Deficiency in CD22, a B Cell–specific Inhibitory Receptor, Is Sufficient to Predispose to Development of High Affinity Autoantibodies , 1999, The Journal of experimental medicine.

[57]  J. Copeman,et al.  Crosses of NOD mice with the related NON strain. A polygenic model for IDDM. , 1995, Diabetes.

[58]  M. Seldin,et al.  Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci , 1992, The Journal of experimental medicine.

[59]  E. Wakeland,et al.  Genetic dissection of systemic lupus erythematosus. , 1999, Current opinion in immunology.

[60]  M. M. Griffiths,et al.  Mapping autoimmunity genes. , 1999, Current opinion in immunology.

[61]  B. Croker,et al.  Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. , 1999, Immunity.

[62]  D. Baker,et al.  Genetic analysis of experimental allergic encephalomyelitis in mice. , 1995, Journal of immunology.

[63]  D. Lacey,et al.  Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[64]  T. Kamoto,et al.  Host modifier genes affect mouse autoimmunity induced by the lpr gene. , 1997, The American journal of pathology.

[65]  J. Trent,et al.  Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  F. Eitner,et al.  Improved survival and amelioration of nephrotoxic nephritis in intercellular adhesion molecule-1 knockout mice. , 1998, Journal of the American Society of Nephrology : JASN.

[67]  K. Blenman,et al.  The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[68]  M. Walport,et al.  Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. , 1998, Journal of immunology.

[69]  M. Walport,et al.  C1q and systemic lupus erythematosus. , 1998, Immunobiology.

[70]  K. Ochiai,et al.  Genetic regulation of anti-erythrocyte autoantibodies and splenomegaly in autoimmune hemolytic anemia-prone new zealand black mice. , 2000, International immunology.

[71]  J. Bluestone,et al.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.

[72]  Pier Paolo Pandolfi,et al.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies , 1998, Nature Genetics.

[73]  R. Holmdahl,et al.  Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis , 1995, Nature Genetics.

[74]  E. Blankenhorn,et al.  Genetic factors in demyelinating diseases: genes that control demyelination due to experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalitis virus. , 1992, Regional immunology.

[75]  D. Baltimore,et al.  Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. , 2009, Immunity.

[76]  X. Montagutelli,et al.  Linkage of a major quantitative trait locus to Yaa gene‐induced lupus‐like nephritis in (NZW × C57BL/6)F1 mice , 1998, European journal of immunology.

[77]  J. Cyster,et al.  Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. , 1998, Immunity.